Mazor gets new FDA approval

The firm's SpineAssist device gets a nod for a wide range of procedures.

Mazor Surgical Technologies Ltd. (TASE:MZOR) has obtained US Food and Drug Administration (FDA) approval to extend the application of the company's SpineAssist imaging and robotic device for assisting in spinal surgical procedures. The FDA has extended use of SpineAssist to the neck vertebrae, in addition to the upper and lower spine.

The approval will also enable SpineAssist to be used in minimally invasive surgery.

The FDA now also allows the device to be placed on the surgical table instead of on the patient. This permit is essential for use of SpineAssist in conjunction with GO-LIF, which Mazor is jointly developing with the Cleveland Clinic Foundation. This procedure enables the setting of two vertebrae from a diagonal position, rather than cutting through the back muscle.

Published by Globes [online], Israel business news - - on May 28, 2008

© Copyright of Globes Publisher Itonut (1983) Ltd. 2008

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017